NCT07129434

Brief Summary

It is both timely and important to invest in interventions that can improve healthy emotional co-regulation. It is proposed to evaluate the feasibility and limited efficacy of an adapted, brief, multimodal intervention: ECoFam (Emotional connection and Co-regulation for Families). Evidence from the US suggests intervention effects on maternal and infant outcomes that are large in effect size (i.e., Cohen's d \>0.6 for increasing emotional connection and decreasing maternal depressive symptoms) (21-23). The study results will directly translate evidence into practice and, if found feasible, allow rapid scaling-up. Objectives:

  1. 1.Build capacity for implementation of a novel diagnostic screening tool for emotional co-regulation, the uWECS, as part of clinical follow-up for mother-infant dyads with high fibrobesity risk in Finland.
  2. 2.Test the feasibility and limited efficacy of the brief, multimodal ECoFam intervention to foster healthy emotional co-regulation between mothers with PCOS and obesity and their infants.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Apr 2025Dec 2026

Study Start

First participant enrolled

April 15, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 19, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

1.2 years

First QC Date

August 4, 2025

Last Update Submit

August 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Universal Welch Emotional Connection Screen (uWECS)

    Emotional connection evaluated with the uWECS

    From enrollment to the end of intervention and follow-up at 4 months

Secondary Outcomes (1)

  • Mothers' mental health problems

    From enrollment to end of intervention and follow-up 4 months

Study Arms (2)

ECoFam intervention

EXPERIMENTAL

personalized coaching sessions

Behavioral: ECoFam

treatment-as-usual (TAU)

NO INTERVENTION

control group, no intervention administered

Interventions

ECoFamBEHAVIORAL

Mother-infant dyads randomized into the intervention group receive four personal coaching sessions to facilitate emotional connection via multisensory channels including comfort touch and communication of face-to-face affect during holding time.

ECoFam intervention

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of PCOS
  • Obesity according to BMI
  • Gave birth at Oulu University Hospital in 2024-25
  • PEPPI cohort study participation
  • uWECS emotional connection score \<9.0 at pre-test

You may not qualify if:

  • \- Infant death

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oulu University Hospital

Oulu, Finland

RECRUITING

MeSH Terms

Conditions

Polycystic Ovary SyndromeObesityOverweight

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System DiseasesOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Julia Jäkel, Dr. phil. habil.

    University of Oulu

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Julia Jaekel, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

August 4, 2025

First Posted

August 19, 2025

Study Start

April 15, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 19, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations